HomeENLV • NASDAQ
add
Enlivex Therapeutics Ltd
Previous close
$1.15
Day range
$1.07 - $1.11
Year range
$0.81 - $2.10
Market cap
26.24M USD
Avg Volume
192.22K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 3.08M | 3.08% |
Net income | -1.87M | 39.66% |
Net profit margin | — | — |
Earnings per share | -0.08 | 50.00% |
EBITDA | -2.99M | -5.91% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 19.51M | -24.81% |
Total assets | 22.60M | -29.16% |
Total liabilities | 3.54M | 6.11% |
Total equity | 19.05M | — |
Shares outstanding | 23.86M | — |
Price to book | 1.44 | — |
Return on assets | -33.00% | — |
Return on capital | -37.85% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -1.87M | 39.66% |
Cash from operations | -1.20M | 33.33% |
Cash from investing | 1.07M | 234.63% |
Cash from financing | 0.00 | -100.00% |
Net change in cash | -129.00K | -107.06% |
Free cash flow | -1.11M | -618.16% |
About
Founded
Jan 22, 2012
Website
Employees
36
